MTHFR and rectal cancer: Terrazzino et al. [8] found that in rectal cancer patients receiving 5-FU-based chemotherapy and radiotherapy, patients not carrying the MTHFR 677T-1298A haplotype exhibited a higher response rate than patients with the MTHFR 677T-1298A haplotype (P = 0.002).